In an environment where biotech startups are being asked to do more with less, building the right operational foundation is no longer a “nice to have” – it’s essential. That’s why Prendio-BioProcure and CFGO have joined forces to deliver a powerful, integrated solution that helps emerging life science companies scale faster, smarter, and with greater financial confidence.
This partnership is designed with one goal in mind: to help early-stage biotechs get their financial house in order and bring together procurement, AP, and financial strategy in a way that supports scientific discovery and fuels long-term growth.
Meeting the Moment: Stability and Speed in a Shifting Biotech Market
The current biotech landscape is marked by uncertainty. With tighter funding cycles and heightened scrutiny from investors, startups need clear financial visibility, operational discipline, and the ability to scale without sacrificing compliance or agility.
Together, Prendio-BioProcure and CFGO are delivering just that.
Prendio-BioProcure offers a source-to-pay solution purpose-built for life science R&D, combining an intuitive procurement platform with outsourced purchasing services.
CFGO provides fractional CFO and accounting support tailored to the needs of early-stage life science companies, helping them build investor-ready systems and processes.
By partnering, the two organizations help biotech teams go beyond tactical purchasing or accounting fixes, empowering them with the scalable infrastructure needed to survive and thrive in today’s market.
Real-World Impact: Trace Neuro’s Growth Story
A compelling example of the partnership’s value is Trace Neuro, a fast-growing biotech that raised its Series A in 2024. As the company advanced its scientific programs, leadership recognized the opportunity to strengthen operational foundations to support rapid growth.
Like many early-stage biotechs, Trace Neuro was using a mix of systems to manage lab and business spend—BioProcure for scientific purchasing, and manual processes for other expenses. To prepare for the demands of scaling, they partnered with Prendio-BioProcure and CFGO to establish greater structure, visibility, and financial discipline.
Together, the teams streamlined operations and implemented scalable workflows that empowered Trace Neuro to move faster with greater control. Key outcomes included:
- Centralized Procurement: All purchasing was unified under Prendio-BioProcure, enhancing compliance without slowing down the science.
- Scalable Financial Ownership: Approval flows were realigned, and coding consistency was established between QuickBooks and Prendio.
- Change Management Support: CFGO led hands-on training and system adoption, ensuring long-term usability and team-wide buy-in.
The result? Trace Neuro now benefits from faster invoice processing, real-time budget visibility, and an investor-ready financial foundation, enabling smarter, faster decisions across the organization.
Read more about Trace Neuro’s success.
A Blueprint for Biotech Scale
For startups navigating uncertain waters, partnerships like this provide more than operational efficiency—they deliver peace of mind. By aligning purchasing systems with financial oversight and forward-looking strategy, biotechs gain:
- Improved compliance and reduced risk
- Greater transparency across all spend
- Faster, data-driven decisions
- Stronger investor confidence
As Prendio-BioProcure and CFGO continue to expand their collaboration, the message to biotech founders is clear: You don’t have to scale alone, and you shouldn’t have to choose between scientific focus and financial discipline.
See what’s possible with Prendio-BioProcure. Let’s simplify your procurement and scale smarter.